FDA 483 - My CHS Rx, Inc. - June 05, 2026

My CRS Rx, Inc., a drug repackager and relabeler in Hauppauge, NY, was cited for significant deficiencies in its quality system during an FDA inspection. The firm lacked a functional quality control unit, failed to implement a CGMP training program for employees, and did not properly qualify equipment or validate packaging and labeling processes. These issues indicate a broad failure to adhere to current good manufacturing practices.